Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

67.12  -8.35 (-11.06%)

After market: 67.92 +0.8 (+1.19%)

Fundamental Rating

3

RBLX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 71 industry peers in the Entertainment industry. While RBLX seems to be doing ok healthwise, there are quite some concerns on its profitability. RBLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RBLX has reported negative net income.
RBLX had a positive operating cash flow in the past year.
In the past 5 years RBLX always reported negative net income.
RBLX had a positive operating cash flow in each of the past 5 years.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -15.54%, RBLX is not doing good in the industry: 77.27% of the companies in the same industry are doing better.
RBLX has a Return On Equity of -547.38%. This is amonst the worse of the industry: RBLX underperforms 80.30% of its industry peers.
Industry RankSector Rank
ROA -15.54%
ROE -547.38%
ROIC N/A
ROA(3y)-15.55%
ROA(5y)-13.94%
ROE(3y)-632.04%
ROE(5y)-462.51%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -500 -1K -1.5K

1.3 Margins

With an excellent Gross Margin value of 77.58%, RBLX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Gross Margin of RBLX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RBLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y-0.19%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBLX has been increased compared to 1 year ago.
Compared to 5 years ago, RBLX has more shares outstanding
The debt/assets ratio for RBLX has been reduced compared to a year ago.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.69 indicates that RBLX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.69, RBLX belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
RBLX has a debt to FCF ratio of 1.68. This is a very positive value and a sign of high solvency as it would only need 1.68 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.68, RBLX belongs to the top of the industry, outperforming 80.30% of the companies in the same industry.
RBLX has a Debt/Equity ratio of 5.30. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RBLX (5.30) is worse than 78.79% of its industry peers.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 5.3
Debt/FCF 1.68
Altman-Z 3.69
ROIC/WACCN/A
WACC8.94%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.98 indicates that RBLX may have some problems paying its short term obligations.
With a Current ratio value of 0.98, RBLX perfoms like the industry average, outperforming 51.52% of the companies in the same industry.
RBLX has a Quick Ratio of 0.98. This is a bad value and indicates that RBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
RBLX has a Quick ratio of 0.98. This is comparable to the rest of the industry: RBLX outperforms 53.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.02% over the past year.
Looking at the last year, RBLX shows a very strong growth in Revenue. The Revenue has grown by 27.98%.
The Revenue has been growing by 53.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)12.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.44%
Revenue 1Y (TTM)27.98%
Revenue growth 3Y44.7%
Revenue growth 5Y53.83%
Sales Q2Q%34.44%

3.2 Future

The Earnings Per Share is expected to grow by 13.38% on average over the next years. This is quite good.
Based on estimates for the next years, RBLX will show a quite strong growth in Revenue. The Revenue will grow by 17.19% on average per year.
EPS Next Y15.07%
EPS Next 2Y10.99%
EPS Next 3Y10.43%
EPS Next 5Y13.38%
Revenue Next Year28.1%
Revenue Next 2Y23.75%
Revenue Next 3Y21.96%
Revenue Next 5Y17.19%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBLX. In the last year negative earnings were reported.
Also next year RBLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50

4.2 Price Multiples

RBLX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 73.56
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.99%
EPS Next 3Y10.43%

More info and screens

0

5. Dividend

5.1 Amount

RBLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROBLOX CORP -CLASS A

NYSE:RBLX (2/6/2025, 7:04:24 PM)

After market: 67.92 +0.8 (+1.19%)

67.12

-8.35 (-11.06%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)02-06 2025-02-06/bmo
Inst Owners72.33%
Inst Owner Change-4.79%
Ins Owners5.41%
Ins Owner Change-0.86%
Market Cap44.05B
Analysts78
Price Target61.12 (-8.94%)
Short Float %3.82%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.48%
Min EPS beat(2)13.59%
Max EPS beat(2)19.36%
EPS beat(4)4
Avg EPS beat(4)15.36%
Min EPS beat(4)7.73%
Max EPS beat(4)20.74%
EPS beat(8)6
Avg EPS beat(8)9.44%
EPS beat(12)6
Avg EPS beat(12)-9.47%
EPS beat(16)7
Avg EPS beat(16)-56%
Revenue beat(2)2
Avg Revenue beat(2)6.21%
Min Revenue beat(2)4.23%
Max Revenue beat(2)8.2%
Revenue beat(4)3
Avg Revenue beat(4)3.34%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)8.2%
Revenue beat(8)3
Avg Revenue beat(8)-3.32%
Revenue beat(12)3
Avg Revenue beat(12)-9.07%
Revenue beat(16)3
Avg Revenue beat(16)-15.02%
PT rev (1m)7.99%
PT rev (3m)31.12%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0.37%
EPS NY rev (3m)3.27%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)6.49%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)3.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.09
P/FCF 73.56
P/OCF 56.39
P/B 231.93
P/tB 4796.41
EV/EBITDA N/A
EPS(TTM)-1.61
EYN/A
EPS(NY)-1.44
Fwd EYN/A
FCF(TTM)0.91
FCFY1.36%
OCF(TTM)1.19
OCFY1.77%
SpS5.13
BVpS0.29
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.54%
ROE -547.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.58%
FCFM 17.8%
ROA(3y)-15.55%
ROA(5y)-13.94%
ROE(3y)-632.04%
ROE(5y)-462.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 5.3
Debt/FCF 1.68
Debt/EBITDA N/A
Cap/Depr 79.39%
Cap/Sales 5.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 3.69
F-Score6
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)207.68%
Cap/Depr(5y)237.4%
Cap/Sales(3y)12.14%
Cap/Sales(5y)13.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.44%
EPS Next Y15.07%
EPS Next 2Y10.99%
EPS Next 3Y10.43%
EPS Next 5Y13.38%
Revenue 1Y (TTM)27.98%
Revenue growth 3Y44.7%
Revenue growth 5Y53.83%
Sales Q2Q%34.44%
Revenue Next Year28.1%
Revenue Next 2Y23.75%
Revenue Next 3Y21.96%
Revenue Next 5Y17.19%
EBIT growth 1Y2.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year160.96%
EBIT Next 3Y45.72%
EBIT Next 5Y29.33%
FCF growth 1Y952.34%
FCF growth 3Y-32.94%
FCF growth 5Y28.86%
OCF growth 1Y109.81%
OCF growth 3Y-4.39%
OCF growth 5Y35.31%